This report presents an overview of the Biotechnology market in Japan. After giving a comprehensive definition of biotechnology, this report focuses on the characteristics of this market by providing information on its size and structure. Furthermore it includes information concerning biotech regulation in Japan as well as a complete list of major players and their specificities on the Japanese market. Lastly, this report provides various recommendations to EU companies for a successful market entry.
About the Expert:
Mr Satoh began his career as brand manager and market research manager in automobile companies, before working for a pharmaceutical company as market analyst. Since a few years, Mr Satoh is member of Fenetre Partners and is in charge of market researches. Click here to access her profile page.
The recording of the past webinar covering this topic is available for online viewers here. (Once you are logged in, look for the link below the "After event information")
Picture: Plant tissue culture facility
Copyright: From public domain.
How is Japanese biotech R&D structured, who are the key stakeholders, and how can European SMEs profit and find Japanese partners? Japan spends consistently over 3% of its GDP on R&D, of which some 70
This website and related activities are managed by the EU-Japan Centre for Industrial Cooperation, a joint venture between the European Commission's Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) and the Japanese Government's Ministry of Economy, Trade & Industry (METI).
No less than 300 web pages with up-to-date information on Japan, more than 170 reports available as well as a lot of detailed information on the Japanese business culture.